Lower respiratory tract infection  by unknown
8 0  Clin ica l  M i c r o b i o l o g y  a n d  I n f e c t i o n ,  Volume 5 S u p p l e m e n t  3 
prevention of cervical dysplasia and cancer, and also in the control of 
HIV infection 
[0104) Oral GS4104 in the treatment of naturally 
acquired influenza is effective and benefits 
health and activity status 
A. Osterhaus, F. Aoki, Y. Wegmiiller, H. Jackson, L. Huson, 
P. Ward. Erasmus University, Hofft Afdeling Virologie, Rotterdam, The 
Netherlands 
Objectives: To evaluate the efficacy of GS4104 (Ro64-0796), the 
prodrug of GS4071, a potent and selective neuraminidase inhibitor 
for the treatment of naturally acquired influenza infection and its 
impact on health and activity status 
Methods: Healthy non-immunized adults aged 18-65 years with 
a temperature of 38T and at least one respiratory and one consti- 
tutional symptom were randomized within 36 h of symptom onset 
to receive oral GS4104 75 mg or 150 nig or placebo (P) b.i.d. for 5 
days. The primary endpoint of this placebo-controlled, double-blind 
study was time to alleviation of illness in influenza-infected subjects. 
Secondary outcomes included symptom score AUC and the impact 
on health and activity status 
Results: O f  719 evaluable subjects, 475 (66%) had confirmed 
infection. Duration of illness was reduced by 30% in both treatment 
arms compared with P (P/75/150: 116.5, 87.4 (p=0.17), 81.8 h 
(p<0.007)). Treatment within 24 h of symptom onset reduced 
duration of illness by 40%. Severity of illness was reduced and the 
proportion of subjects remaining febrile after 36 h was reduced by 
60% compared with P. Oral GS4104 was associated with significantly 
better health status, daily performance and quality of sleep compared 
with P. This improvement was observed as early as 24 h after initiating 
therapy. Transient gastrointestinal effects were slightly more common 
in the active drug arms, and discontinuations were similar in all three 
dose groups 
Conclusions: Early treatment of acute influenza with oral 
GS4104 reduces both duration and severity of influenza symptom 
burden, is well tolerated, and significantly impacts on patients' overall 
health and activity status. 
Lower respiratory tract infection 
LO1 05 I Community-acquired lower respiratory tract 
infections in the elderly: a prospective study 
J. Flamaing', M. Van Ranst', W.E. Peetermans3. 'Division of 
Geriatric Medicine, 'Dqmrtment of VirologJ, 'Division of" General 
Internal Medicine, Katliolieke Universiteit Leuven, Leuven, Belgium 
Objectives: To determine the causes of lower respiratory tract 
infections (LRTIs) in elderly subjects (69 years of age) admitted to an 
acute geriatric ward during the winter of 1997-98 
Methods: Standard sputum and blood cultures for bacteriology 
A nasopharyngeal swab for respiratory syncytial virus (RSV) antigen 
detection and RSV, influenza, parainfluenza and adenovirus culture 
was obtained. Acute and convalescent sera for these viruses was 
obtained as well as for Mycoplasma pneumoniae and Chlamydia 
Results: One hundred and sixty-five elderly subjects (mean age 
82 years) were admitted with a LRTI, including 89 pneumonias 
(54%), 52 cases ofbronchitis (31.5%) and 24 exacerbations ofchronic 
obstructive pulmonary disease (14.5%). The overall mortality was 
13.3% (22/165). A definite diagnosis was possible in 63 patients 
(38.2%) (6 RSV, 46 influenza, and 2 parainfluenza infections, 
1 Mycoplasma pneumoniae infection, 6 Streptococcus pneumoniae 
bacteremias, 1 Staphylococcus aureus bacteremia,l Gram-negative 
sepsis). A positive nasopharyngeal swab was obtained in 39.7% of 
patients (25163, 24 influenza, 1 RSV). Serology contributed to the 
diagnosis in 47.6% (30/63), the nasopharyngeal swab in 4.7% (3/63) 
and both in 34.9% (22/63). A possible pathogen was identified in 27 
of 79 (34.2%) by sputum culture. A definite or possible cause could 
be established in 54.5% of the study population (90/165). Within 3 
days after admission, a definite diagnosis could be established in 20% 
(331165) and a definite or possible diagnosis in 36.4% (60/165). The 
nasopharyngeal swab contributed to early dagnosis in 75.7% 
Conclusions: The causes of LRTI in the elderly remain difficult 
to document. A nasopharyngeal swab can make a major contribution 
to the early etiologic diagnosis of viral LRTI in community-dwelling 
elderly subjects. 
1- Persistent adenoviral infection and chronic 
obstructive bronchitis in children-is there a 
link? 
M. Pichler', P. Ahrens', H. Schmidt', G. Herrmann4 , S .  Zielen. 
'University of Bonn, 'Zentmm der Kinderheilkunde, 3Zentmm der 
Radiolofie, 4Zentrum der Pathologie, Urziversity of Frankfurt, 
FrankfudM, Germany 
Objectives: To study the prevalence of persistent adenoviral 
infections in children with chronic airway obstruction 
Methods: Chronic obstructive bronchitis with inadequate res- 
ponse to inhaled steroids and bronchodilator therapy is a rather rare 
disorder in children. Persistence of an adenoviral infection has been 
described as a possible cause of unremitting airway obstruction. We 
studied a group of 10 children with the clinical feature of chronic 
bronchial obstruction. HR-CT was performed and typically showed 
hyperinflation and ground-glass-like opacities. All children under- 
went either bronchoscopic transbronchial or open lung biopsy. 
Biopsy specimens were stained with monoclonal antibodies detecting 
adenoviral antigens and analyzed at the light-microscopic level. BAL 
fluid was cultured for adenovirus and antigen detection tests were 
performed 
Results: Whereas some children had a history of proven adeno- 
viral infection at the onset of disease or showed high serologic titers 
of anti-adenoviral antibodies, in none of the cases could persistence 
of adenovirus be shown 
Conclusions: We conclude that adenoviral infection might act as 
a starter of chronic obstructive bronchitis in children, but that patho- 
genetic mechanisms other than persistent infection must be 
responsible for the disease becoming chronic 
101071 Detection of Mycoplasma pneumoniae in 
children with wheezing 
S .  Esposito, E Blasi', L. Fusetti, C. Arosio', P. Tarsia', N. Morelli', 
L. Allegra', N. Principi. Paediatric Department l y  L. Sacco Hospital, 
Institute of Respiratory Diseases, IRCCS Ospedale Maaiore, University 
ofMilan, Italy 
Objective: To evaluate the role of Mycoplasma pneumoniae infection 
in children with wheezing 
A b s t r a c t s  81 
Methods: Fifty-nine children between the ages of 2 and 14 years 
(35 females, median age 4.4 years) with a history ofrecurrent reactive 
airway diseases presenting to the pediatric emergency department 
with an acute episode of wheezing were studied. Serum samples for 
antibody testing and nasopharyiigeal aspirates for polymerase chain 
reaction (PCR) for M .  ptieumoniac were obtained on  adniission and 
after 4-8 weeks from all the patients. Each of the sera was tested for 
IgM and IgG antibodies to M.  pneumoniae by an enzyme-linked 
101091 Procalcitonin as a prognostic factor in patients 
with severe pneumonia 
EM. Brunkhorst'. B. Al-Nawas', E Kruiiinienaucr', J. Forycky', 
PM. Shah'. ' h e r t ~  .Wed. I/Kardiolo@ irnd Inictisiviriedirii~, Hubpiid 
Neukdlrt, Berlirr, 'Maxillufcial Sirgery,  ';Vfedi~iriisrhc StotDtik itrid 
Dokirmeritatiori Uriiuersity Hospital Mairiz, ' M r d .  Kliriik I l l /  
It!f;.ktiolo,qie, Uniivrsity Hospital Frankfrrrt t.M., Germany 
iiiiinunosorbent assay, using commercial kits (Pantec, Turin, Italy). 
P C R  was performed as previously described. None of  the children 
was treated with antibiotics 
Results: Thirteen children with wheezing (22%) showed acute 
M. ptie!rmoriiae infection. Eight subjects showed IgM seroconversion 
to M. pneumoniae, whereas five patients presented a fourfold increase 
in IgG-specific titer. PCK for M .  pneumoniae i r m  negative on  all 
samples tested. Only three of 13 M .  pnenmotiiae-infected children 
showed a complete resolution of wheezing-related symptoiiis after 
4-8 weeks 
Conclusions: A significant relationship seems to exist between 
M .  piieuwiiwiiae infection and wheezing in children. Treatment of M .  
pnertrnoniae infection may improve the course of reactive airway 
disease in these children 
101081 Multicenter evaluation of molecular typing 
methods for Legioneffa pneumopbik 
serogroup 1 
N.K. Fry, T.G. Harrison, on behalf of members of the European 
Working Group for Legionella Infections. 'Respiratory a d  Systeniir 
Ir!fiction hhoratory,  PHLS Ceiitral Public Hcaltlt Laborafury, Londow, 
UK 
Objectives: In 1997, a pan-European study was initiated to evaluate 
a range of molecular methods for the epidemiologic typing of 
k ' q i o r d l a  pnr~iimophila serogroup 1. A coded panel of 115 strains was 
analyzed by 12 typing centers in 11 European countries using 
restriction endonuclease analysis, ribotyping, restrictioii fragment 
length polymorphism analysis, pulsed-field gel electrophoresis, 
APPCR, and noii-fluorescent amplified fragment length poly- 
morphism (AFLP) analysis. AFLP analysis appeared to offer a 
relatively rapid and reproducible means of differentiating epideniio- 
logically related aiid unrelated strains. Consequently, in 1998, the 
next phase of this study was to assess the reproducibility of this 
methodology 
Methods: A panel of 50 strains of L. pneirniop/zilo serogroup 1, for 
which good epidemiologic data were available, was prepared. coded 
and sent to  13 laboratories in 12 countries and analyzed by AFLP 
according to an agreed standard protocol. Any variations were noted 
by participants 
Results: The results revealed excellent within-laboratory repro- 
ducibility. Several centers also allocated the same strains to the same 
Introduction: Procalcitonin (PCT) is a peptide consisting of 
116 amino acids. In healthy volunteers, sei-iiiii concentration, of 
<O.S ng/iiiL are found; however, in patients with sepsis aiid severe 
infections, elevated concentrations exceeding the baseline levels by 
up to 1000-fold are reported by many authors 
Objectives: To determine the value of PCT as a prognostic fnctor 
in patients with severe pneumonia 
Methods: In a prospective study i n  93 patients with piieniiionia 
according to the C D C  guidelines who were at the iioii-surgical ICU 
of the Hospital Neukolln Berlin, PCT was monitored. I>eiiiogr~ipIiic 
data and laboratory parameters were docuiiientcd. APACHE 11 scorc 
was deterniined daily. Outcome (death versus restitution) was 
documented. The Mann-Whitney test was used to test for \ignificant 
differences 
Results: Survivors/non-survivors. Statistically diffcrcnt values are 
marked by I ,  
Day- -PCT- -CKP- APACHE ri  
(ng/mL) - - - (mg/dL)- - - - scorc ----- 
0-1 - -  - - 9 / 1 1 - -  - - 1 9 / 1 8 - -  - -22/27 '  
2-3 - - - 15/16 - - - 20.4/24.2 - - - 19/25' 
4-6 -- - 6.3/11' - - 15.2/20.7 - - - 18/25' 
7-10 - - 1.7/9.81 - 13.2/17.4 - - -  18/28' 
11 - 1.2/7.4' - - lS/IX - - - 10/35' 
Conclusion: PCT, CKP and APACHE 11 scores on adiiiission to 
the ICU are not statistically useful for evaluating the prognosis of 
pneumonia. However, declining PCT values in the course of the 
disease correlate with survival, and increasing APACHE I1 \coi-c with 
non-survival 
lm Efficacy of sulbactam/ampicillin (SBT/AMP) 
versus clindamycin-ecefotixam (CLI-cCEF) in 
the treatment of aspiration pneumonia or 
pulmonary abscess 
I? Schiiler', H. Lode', U.Boleskei'. l D ~ p ~ r ~ n ~ c ~ ~ ~  of Cliest arid 
Ii?fectioirs Diseases, Hospital Heckeskorw, Bcr/iti, 2Dcprtriiozr of CXi>st 
Diseases, Klinikunt Nitrd~ey ,  h'~rrcrn/~tyq, Cermnf iy  
Objectives: Aspiration pneumonia and pulmonary abscesses ,ire 
usually of polyniicrobial origin and frequently involve anaerobic bac- 
teria. In this multicenter prospective randomized study, we compared 
SBT/AMP with CLIkCEF in the treatiiient of aspiration 
meunionia and ~iilnionarv abscesses 
VPe 
Conclusions: Preliminary results indicate that the AFLP method 
provides an acceptable level of discrimination and reproducibility and 
can provide useful epidemiologic data within an acceptable tinie- 
frame. This study shows the potential for this method to be used for 
true epideniiologic typing (by collaborative centers), by the allocation 
of definitive types 
Methods: Ninety-five inpatient5 with radiologic and clinical ~ i g i ~ s  
of aspiration pneumonia/pulnionary abscess were enrolled by eight 
German study centers between April 1995 to August l99X after 
written informed consent. All patients underwent bronrhoscopy 
with protected specinien brush for analysis of aeroblc and anaerobic 
bacteria. Treatment was started parenterally for a t  least 6 days (3x3 g 
S13T/AMP, 3x600 mg CLI23X2 g CEF) and was continued orally 
(2x750 mg SBT/AMP, 3 x 3 0 0  nig CLI) until nornializatioii of 
clinical, laboratory and radiologic finding 
Results: According to preliminary analysis, 73 of the 9.5 included 
patients enrolled (SBT/AMP: 38, mean age 58 years; CLI?+CEF: 35, 
mean age 59 years) were evaliiable for efficacy Anaerobic bacter~a 
alone were detected in 6%, aerobes in 64'K, both combined in 14'%1, 
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and no growth in 16%~. Clinical cure or improvement in the evaluable 
patients were 5(W and 21% recpectively in the SBTIAMP group, and 
34% and 34%) respectively in the CLIkCEF group. Mean durations 
of treatment were 22 days and 24 days in the SBT/AMP and CLI 
h CEF group, respectively. Bacteriologic eradication was achieved in 
22/29 (76%) in the SBT/AMP and in 11/15 (73%) in the CLIfCEF 
patients 
Conclusion: In the treatment of pulmonary a$pipiration and 
pulmonary abscess, SBT/AMP is at least as efficacious as CLIkCEF 
101121 Susceptibility of respiratory bacterial 
pathogens to azithromycin 
I. Goic-Barisic, K. Sisko-Kraljevic, M. Tonkic, S. Sardelic, 
J. Karanovic, V Punda-Polic. Department of Clinical Microbiolog]), 
University Hospital, Split, Croatia 
Azithromycin has been in clinical use for 10 years. In recent years 
there has been a marked growth of resistance of clinical isolates, 
especially in Spain and Italy 
Objectives: To determine the susceptibility to azithromycin of 
clinically significant bacterial agents isolated from respiratory tracts in 
University Hospital Split, Croatia 
Methods: From January 1997 to September 1998, the suscepti- 
bility of 1978 bacterial isolates from respiratory tract specimens was 
analyzed. Susceptibility testing was performed by the disk diffusion 
method following the NCCLS guidelines. Disk strength was 1 5 p g  
azithromycin. The following species were studied Sraphylococcns 
anreus (n=982; MSSA, n=637), Streptococcus pneunroniae (n=368), 
Haemophilus influenzae (n=322) ,  S. agaalactiae (n= 102). Streptococcus 
spp. (n= 148) and Streptococcus pyogen~s (rt=56) 
Results: The percentages of strains categorized as susceptible (S), 
intermediate (I) or resistant (R) are given in the table: 
Among the strains of Streptococcus pneumoniae yielding zones of 
inhibition surrounding the 1-pg oxacillin disk of <19 nim (62.5% of 
total), 169 of 230 (73.5'5) were susceptible to azithromycin 
Conclusion: We conclude that azithromycin could be a useful 
therapeutic option in respiratory tract infections due to the most 
common bacterial pathogens. Moreover, a clinical benefit could be 
expected if strains of penicillin-resistant Streptococcus pneumuwiae are 
isolated 
1-1 Treatment of respiratory tract infections (RTls) 
in adults with 3 days of azithromycin: a meta- 
analysis 
D. Pontani, K.D. Agostino Jr. G. Treadway. @zer Pharmaceuticals 
Group, New l b rk ,  Nt: CJSA 
A meta-analysis was conducted to compare the efficacy of 3-day, 
once-daily azithromycin (AZ) versus three classes of first-line anti- 
microbials (penicillin, cephalosporin, and macrolide), given as 
multiple daily doses for 5-10 days, for KTI treatment in adults. A 
worldwide computerized literature search in English was performed 
(only randomized, comparative studies with more than 10 evaluable 
patients per treatment arm included); 20 studies met the inclusion 
criteria. Of 4652 adult, clinically evaluable patients, 2510 received 
azithroniyciii and 2142 penicillin V, anioxycillin, cefaclor, roxithro- 
mycin, clarithromycin or  anioxycillin-clavulanic acid (COMP). Data 
were grouped and analyzed by URTI (otitis media, sinusitis, 
pharyngitis) or LRTI (acute bronchitis, acute exacerbation of chronic 
bronchitis, pneumonia). At treatment end, clinical success rates 
(cured+improved) were similar for both treatment arins in URTI 
(94.5% AZ, 95.6% COMP) and LRTI (92.8% Az, 91.9% COMP). 
At study end, reported clinical success for AZ was 90S% for URTI 
and 80.9% for LRTI. For COMP, it was 87.2% and 71.8%, res- 
pectively. Bacteriologic eradication rates for A 2  and COMP were 
between 84.9% and 90.5% at treatment end, and 93.3% and 93.1% 
at study end. In conclusion, once-daily, 3-day treatment with AZ was 
as effective as multiple daily-dose treatment with the other first-line 
therapies given for 5-10 days. With once-a-day dosing and shorter 
treatment time, AZ has the advantage of better compliance, with 
equal clinical benefits, for the empirical therapy of both URTI and 
LRTI. and offers a safe and effective treatment alternative. 
A b s t r a c t s  8 3  
/0114] Economic evaluation of the management of 
community-acquired pneumonia (CAP) by 
general practitioners (GPs) in France 
13. Fantin', EUKAXI', SFTG', C. Carbon'. 'INSER.41 ( 7  I.?, 
Paris; ' " V c t i r w k / &  dic study of CZ4e Frufite 
The cost of the nianagement of 130 CAE's by 50 GI's was pros- 
pectwely invcrtigated between October 1995 and March 1997 in  1 1 
Frcnch counties. The cox of direct medical resources (mean direct 
medical cost: MDMC:) for the 108 outpatients was171 Euro, which 
wa \  due to antibiotic treatment (37%), consultations (28'%1), diag- 
nogtic procedures (1 9'%1), physiotherapy (8%), non-antibiotic medica- 
tions (5%) and dJy-care hospitalization (3'%1). The mean cost of sick 
leaves adjusted for the 108 patients was 92 Euro. The MIIMC for the 
22 hospitalized patient!, was 5215 Euro. MDMC of successful 
dnibulatory antibiothrrapy (cure without antibiotic chdnge or 
hospitalization, n=75) was 153 Euro. It was 21 1 Euro when d change 
in antibiotic treatment was required without hospitalization (w=33, 
p<O.Ol), and 1293 Euro in the case of a change in antibiotic therapy 
and/or hospitaliz~tion (ri=42, p<O.OOt). Logistic regression analysis 
of the factors associated with a high cost of CAP identified two kinds 
of parameters: those related to the initial clinical condition (concul- 
tatioii at home (RR=h, p<0.03) ,  worrying condition (1<1<=4, 
p<O.Ol)), and those related to the management (need for four 
consultdtions (RR=41, p<O.OOl), for physiotherapy (RR=21, 
p<O.Ol), use of an injectable third-generation cephalosporin 
(RR=lO, p<0.03)). 
